NovaBridge Biosciences (NBP) EBITDA (2019 - 2025)
NovaBridge Biosciences (NBP) reported EBITDA of -$86.2 million for Q4 2025, down 127.73% year-over-year from $310.7 million in Q4 2024, and down 884.88% quarter-over-quarter from $11.0 million in Q3 2025.
NovaBridge Biosciences (NBP) EBITDA (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 5 years of EBITDA data on file, last reported at -$86.2 million in Q4 2025.
- EBITDA for Q4 2025 came in at -$86.2 million, down 127.73% year-over-year; the trailing twelve-month figure through Dec 2025 was -$80.2 million (down 4326.57% YoY), and the FY2025 annual result was -$80.2 million, down 180.18% from the prior year.
- EBITDA eased to -$86.2 million in Q4 2025 per NBP's latest filing, from $11.0 million in the prior quarter.
- Over five years, EBITDA peaked at $25.1 million in Q2 2024 and troughed at -$86.2 million in Q4 2025.
- A 3-year average of -$12.8 million and a median of -$3.1 million in 2025 frame the typical range for EBITDA.
- On a YoY basis, EBITDA climbed as much as 1823.23% in 2025 and fell as far as 127.73% in 2025.
- A 3-year view of EBITDA shows it stood at -$39.5 million in 2023, then increased by 4.13% to -$37.8 million in 2024, then slumped by 127.73% to -$86.2 million in 2025.
- Business Quant data shows NBP's EBITDA at -$86.2 million in Q4 2025, $11.0 million in Q3 2025, and -$1.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -65.83 Mn |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | -86.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -86.16 Mn |
| Sep 30, 2025 | 10.98 Mn |
| Jun 30, 2025 | -1.85 Mn |
| Mar 31, 2025 | -3.15 Mn |
| Dec 31, 2024 | -37.83 Mn |
| Sep 30, 2024 | -637,000.00 |
| Jun 30, 2024 | 25.07 Mn |
| Mar 31, 2024 | 15.29 Mn |
| Dec 31, 2023 | -39.46 Mn |
| Sep 30, 2023 | -10.63 Mn |
| Jun 30, 2023 | -12.05 Mn |
| Dec 31, 2020 | 175.76 Mn |
| Sep 30, 2020 | 88.52 Bn |
| Dec 31, 2019 | -47.37 Mn |
| Sep 30, 2019 | -43.72 Mn |